Abstract
Stomach cancer is the fifth most diagnosed type of cancer and the fourth leading cause of cancer death in the world. Patients with advanced clinical stage (IV) gastric adenocarcinoma have an average survival between 9 and 10 months. Thus, despite advances in the understanding of its biology, it is evident the relevance of identifying new molecular markers that may be useful for the clinic…